Figure - available via license: Creative Commons Attribution-NonCommercial 4.0 International
Content may be subject to copyright.
Source publication
Background:
Pneumonia caused by severe acute respiratory syndrome coronavirus 2 can cause acute respiratory distress syndrome, often requiring prolonged mechanical ventilation and eventually tracheostomy. Both procedures occur in isolation units where personal protective equipment is needed. Additionally, the high bleeding risk in patients with ex...
Contexts in source publication
Citations
... [24]. Another noteworthy recent study, which is one that most closely resembles ours, is that by Son et al. [25]. They performed a retrospective study investigating outcomes of percutaneous dilatational tracheostomy in patients with COVID-19 supported by ECMO (n=17) compared to those without ECMO (n=12). ...
... They, too, noted that their ECMO group was nearly 10 years younger than the non-ECMO group, although their difference did reach statistical significance (56 vs. 68 years, p=.035). Interestingly, their population experienced a higher overall mortality rate without a significant difference between the two groups (53% vs. 58%, p=.792) [25]. ...
Introduction
The coronavirus disease 2019 (COVID-19) pandemic led to the more common use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) for adults with acute respiratory distress syndrome (ARDS). While tracheostomy is generally understood to decrease the risks of prolonged endotracheal intubation, there is conflicting data regarding the benefit of tracheostomy in patients on ECMO. The purpose of this study is to determine whether ECMO cannulation before tracheostomy impacted patient outcomes.
Methods
This is a retrospective chart review of patients who underwent tracheostomy for COVID-19-related ARDS at a tertiary academic center from March 2020 through March 2022. Patients were separated into two groups based on whether they were cannulated for ECMO prior to tracheostomy. Fisher’s exact test or Wilcoxon rank sum test was used to compare the two groups.
Results
A total of 24 patients were included in the study, with 13 in the ECMO group and 11 in the non-ECMO group. There was no significant difference in age, comorbidities, race, or gender between the groups. Patients on ECMO had a longer time from admission to intubation (seven days vs. three days, p=.002), were more likely to have multiple intubations (54% vs 9%, p= .033), had increased rates of postoperative bleeding (62% vs. 18%, p = .047), and had a higher mortality rate (39% vs. 0%, p= .041).
Conclusions
ECMO cannulation prior to tracheostomy for COVID-19-related ARDS is associated with poorer outcomes. It is unclear whether this is related to a more severe disease burden in these patients. Further study is needed to evaluate this and guide future management.
